Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sorrento Therapeutics (SRNEQ)
OTHER OTC:SRNEQ
Sorrento Therapeutics (SRNEQ) Stock Price & Analysis
5,269 Followers
SRNEQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.42
Previous Close$0.02
Volume199.23K
Average Volume (3M)595.50K
Market Cap
$4.41M
Enterprise Value$138.53M
Total Cash (Recent Filing)$80.64M
Total Debt (Recent Filing)$207.60M
Price to Earnings (P/E)>-0.1
Beta1.72
Next Earnings
Aug 10, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.06
Shares Outstanding551,281,154
10 Day Avg. Volume154,732
30 Day Avg. Volume595,495
Standard Deviation0.45
R-Squared0.08
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)0.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.47
Enterprise Value/Gross Profit4.67
Enterprise Value/Ebitda-0.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sorrento Therapeutics News
Ownership Overview
62.34%
Insiders
3.70% Mutual Funds
0.02% Other Institutional Investors
33.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SRNEQ FAQ
What was Sorrento Therapeutics’s price range in the past 12 months?
Sorrento Therapeutics lowest stock price was <$0.01 and its highest was $0.42 in the past 12 months.
What is Sorrento Therapeutics’s market cap?
Currently, no data Available
When is Sorrento Therapeutics’s upcoming earnings report date?
Sorrento Therapeutics’s upcoming earnings report date is Aug 10, 2023 which is 258 days ago.
How were Sorrento Therapeutics’s earnings last quarter?
Sorrento Therapeutics released its earnings results on May 15, 2023. The company reported -$0.257 earnings per share for the quarter, missing the consensus estimate of -$0.16 by -$0.097.
Is Sorrento Therapeutics overvalued?
According to Wall Street analysts Sorrento Therapeutics’s price is currently Overvalued.
Does Sorrento Therapeutics pay dividends?
Sorrento Therapeutics does not currently pay dividends.
What is Sorrento Therapeutics’s EPS estimate?
Sorrento Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sorrento Therapeutics have?
Sorrento Therapeutics has 551,281,100 shares outstanding.
What happened to Sorrento Therapeutics’s price movement after its last earnings report?
Sorrento Therapeutics reported an EPS of -$0.257 in its last earnings report, missing expectations of -$0.16. Following the earnings report the stock price went down -5.882%.
Which hedge fund is a major shareholder of Sorrento Therapeutics?
Among the largest hedge funds holding Sorrento Therapeutics’s share is Graham Capital Management, L.P.. It holds Sorrento Therapeutics’s shares valued at N/A.
---
Sorrento Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Sorrento Therapeutics
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.
---
SRNEQ Stock 12 Months Forecast
Average Price Target
―Technical Analysis
---